Kolon TissueGene Decides on 47.8 Billion KRW Paid-in Capital Increase
Kolon TissueGene announced on the 23rd that it has decided to conduct a paid-in capital increase worth 47.8 billion KRW to secure operating funds.
The company will issue 762,350 common shares at 62,460 KRW per share through a third-party allotment. The third-party allotment target is Kolon Co., Ltd., the largest shareholder.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- With General Strike Looming, Labor Minister Steps In... Samsung Electronics Labor-Management Talks Resume (Update)
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Regarding the selection process, the company stated, "The allocation was made considering the investor's intention and payment capability to achieve management objectives and raise funds."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
